scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1464-410X.2006.06427.X |
P698 | PubMed publication ID | 16978289 |
P50 | author | Theodorus H Van der Kwast | Q56959613 |
Peter J Hendriksen | Q62087192 | ||
P2093 | author name string | Guido Jenster | |
Leonie van der Heul-Nieuwenhuijsen | |||
P2860 | cites work | DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein | Q28577209 |
Delineation of prognostic biomarkers in prostate cancer | Q29617971 | ||
Benign prostatic hyperplasia: an overview | Q33545587 | ||
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia | Q33545598 | ||
Fox's in development and disease | Q34205134 | ||
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer | Q34266112 | ||
The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria | Q34321645 | ||
Role of the stromal microenvironment in carcinogenesis of the prostate | Q35202528 | ||
Gene expression profiling identifies clinically relevant subtypes of prostate cancer | Q35554359 | ||
New targets for therapy in prostate cancer: modulation of stromal–epithelial interactions | Q35579601 | ||
Fingerprinting the diseased prostate: associations between BPH and prostate cancer | Q35613244 | ||
In silico dissection of cell-type-associated patterns of gene expression in prostate cancer | Q35735648 | ||
Predicting prostate cancer behavior using transcript profiles | Q35944511 | ||
Epithelial-mesenchymal interactions in prostatic development. I. morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder | Q36207295 | ||
Amplified RNA synthesized from limited quantities of heterogeneous cDNA. | Q37705357 | ||
Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression | Q40884700 | ||
Forkhead transcription factors contribute to execution of the mitotic programme in mammals | Q42824525 | ||
Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue? | Q46526064 | ||
Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia | Q47816453 | ||
Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions. | Q52168199 | ||
Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics. | Q55039111 | ||
P433 | issue | 4 | |
P304 | page(s) | 886-897 | |
P577 | publication date | 2006-10-01 | |
P1433 | published in | BJU International | Q4835773 |
P1476 | title | Gene expression profiling of the human prostate zones | |
P478 | volume | 98 |
Q37269442 | A comprehensive repertoire of tRNA-derived fragments in prostate cancer. |
Q26741226 | Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia |
Q27339223 | Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease |
Q33728239 | Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models |
Q41839859 | Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies |
Q35905370 | DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells |
Q34868706 | Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate. |
Q46687880 | Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan |
Q80657432 | Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland |
Q24328916 | Distribution of TMEM100 in the mouse and human gastrointestinal tract--a novel marker of enteric nerves |
Q57693373 | ERG rearrangement is present in a subset of transition zone prostatic tumors |
Q35180874 | FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer |
Q28570394 | Gene expression changes are age-dependent and lobe-specific in the brown Norway rat model of prostatic hyperplasia |
Q24311411 | Gene expression of forkhead transcription factors in the normal and diseased human prostate |
Q33878961 | Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells |
Q28590370 | Impairment of endothelial-mesenchymal transformation during atrioventricular cushion formation in Tmem100 null embryos |
Q44664369 | Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer. |
Q36076068 | Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer |
Q33733284 | Low-expression of TMEM100 is associated with poor prognosis in non-small-cell lung cancer |
Q36067907 | Molecular differences in transition zone and peripheral zone prostate tumors |
Q38909020 | Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer |
Q36232052 | Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma |
Q47936649 | Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion |
Q36447329 | Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer |
Q27665926 | Solution structure of the human HSPC280 protein |
Q35088099 | TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers |
Q37046014 | TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry. |
Q38659741 | The androgen receptor plays different roles in macrophage-induced proliferation in prostate stromal cells between transitional and peripheral zones of benign prostatic hypertrophy |
Q37085226 | The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones |
Q35231687 | The functional role of reactive stroma in benign prostatic hyperplasia |
Q37017028 | The stroma-a key regulator in prostate function and malignancy |
Q24292962 | Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis |
Q37074256 | Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate |
Q52588865 | [Pathophysiology and therapy of benign prostatic hyperplasia]. |
Search more.